Stay updated on VAX-24 Safety and Immunogenicity in Adults Clinical Trial
Sign up to get notified when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.

Latest updates to the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision indicator updated from v3.4.1 to v3.4.2 appears in the page footer. No study data, sections, or functionality were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now shows Revision: v3.3.4 in the footer, and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check93 days agoChange DetectedLocations section added with state-level site listings (Florida, Georgia, Indiana, Kansas, Louisiana, Missouri, New York, North Carolina, Rhode Island, South Carolina, Texas, Utah). Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure element.SummaryDifference1%

Stay in the know with updates to VAX-24 Safety and Immunogenicity in Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.